OTEZLA® tablets General use-results survey (BCT) (20200279)

14/08/2020
03/02/2026
EU PAS number:
EUPAS36072
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Study results
Study report
Abstract of study report

apremilast_20200279_Study_Report_Body_Observational_Final_Analysis_.pdf

English (278.48 KB - PDF) View document
Other information